expansion project to the northern of Thailand (phase 1 or NFPT-phase1) which is recognized in this quarter. The Gross profit margin of the Group was of 47.7% compared to 54.5% of Q2/2018. While in the first
par value of 10.00 Baht. The total value 130,000,000 Baht, paid – up as 101,625,000 Baht. Separate into 100,000 ordinary shares has fully - paid of 10 Baht per share, totally in 1,000,000 Baht
statements included the accounts of the Company and its subsidiaries which the operation of subsidiaries have not yet significant, the Management Discussion and Analysis have been submitted based on separate
statements Financial Statement, in which the equity method is applied Separate Financial Statement Changes (separate financial statement) 30-See.19 30-Sep-18 30-Sep-19 30-Sep-1 8 (Million Baht) Yo Revenue from
expansion and/ or refinancing to other purpose as the Board of Directors deems appropriate by issuing from time to time. The Company recorded Dividend payables of 2019 performance in Q1/2020 Baht 3,394
7,698 mn, up by 5.2% YoY with a 6% YoY growth in net profit to THB 2,483 mn. Establishment of a Joint Venture to support business expansion plan On 5 September 2017, the Company established a new joint
unit in a government hospital to provide hemodialysis services (The nd branch) that still has focused on continuous expansion of dialysis unit. On the past 29th September, 2017 the subsidiary
focused on continuous expansion of dialysis unit. On the past 29 th September, 2017 the subsidiary additionally purchased assets from business of a dialysis unit which is business expansion as a plan laid
administrative expense to support business expansion. Without the non-recurring profit related to sale of Dusit Princess Korat, core EBITDA was THB 806 million, a 12.3% decrease from 2016. The Company reported net
such information to the Stock Exchange of Thailand. Reasons and Justifications for the Transaction : The Company has a plan for business expansion, and it is thus necessary for the Company to use more